semaglutide and concerta A Review on Semaglutide: An Oral Glucagon-Like Peptide 1 Receptor Agonist in Management of Type 2 Diabetes Mellitus | Diabetes Therapy Updates in Medicine | Phase

Serious but rare side effects that affect less than 1% of patients include pancreatitis, severe allergic reactions, gallbladder problems, vision problems in diabetics, severe stomach issues, and kidney problems

doi: 10.3389/fnut.2023.1134162 Received 30 December 2022 Accepted 22 June 2023 Published 20 July 2023 Volume 10 - 2023 Edited by Xiaoping Yang, Hunan Normal University, China Reviewed by Lorenzo Lorusso, ASST Lecco, Italy

However, it is important to remember that retatrutide is still undergoing clinical trials to establish its long-term safety and effectiveness before regulatory approval is considered

doi: 10.1016/j.nut.2016.12.018 33 CarcaterraM.CarusoC

Metabolic and hormonal changes during treatment may also influence taste perception

[1] [3] The underlying mechanisms on how carnitine can improve physical performance, if at all, are not clearly understood